HHS OIG Investigated Medicare Reimbursement, Medicaid Rebates

December 04, 2018
The HHS Office of Inspector General has looked into Medicare Part D prescription drug reimbursement, price substitutions in Part B and CMS communications of appropriate rebate amounts in Medicaid, OIG wrote in a summary of its reports published in the second half of 2018. Medicare Part D reimbursement increased, while utilization decreased Medicare Part D reimbursement for brand-name drugs increased 77 percent over a five-year period from 2011 to 2015, an OIG brief found. In that same time, utilization...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.